Lindsay Androski - Jul 1, 2022 Form 3 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Role
Director
Signature
/s/ Sumit Aggarwal, as Attorney-in-Fact for Lindsay Androski
Stock symbol
ELOX
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
3
Date filed
7/6/2022, 09:49 PM
Next filing
Jan 31, 2023

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney